- Home
- MRSN vs LTRN Comparison
MRSN vs LTRN Comparison
Compare MRSN & LTRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRSN
- LTRN
- Stock Information
- Founded
- MRSN 2001
- LTRN 2013
- Country
- MRSN United States
- LTRN United States
- Employees
- MRSN N/A
- LTRN N/A
- Industry
- MRSN Biotechnology: Pharmaceutical Preparations
- LTRN Biotechnology: Pharmaceutical Preparations
- Sector
- MRSN Health Care
- LTRN Health Care
- Exchange
- MRSN Nasdaq
- LTRN Nasdaq
- Market Cap
- MRSN 37.0M
- LTRN 36.0M
- IPO Year
- MRSN 2017
- LTRN 2020
- Fundamental
- Price
- MRSN $7.15
- LTRN $3.91
- Analyst Decision
- MRSN Strong Buy
- LTRN Strong Buy
- Analyst Count
- MRSN 3
- LTRN 1
- Target Price
- MRSN $33.00
- LTRN $25.00
- AVG Volume (30 Days)
- MRSN 62.6K
- LTRN 111.9K
- Earning Date
- MRSN 11-12-2025
- LTRN 11-06-2025
- Dividend Yield
- MRSN N/A
- LTRN N/A
- EPS Growth
- MRSN N/A
- LTRN N/A
- EPS
- MRSN N/A
- LTRN N/A
- Revenue
- MRSN $34,769,000.00
- LTRN N/A
- Revenue This Year
- MRSN N/A
- LTRN N/A
- Revenue Next Year
- MRSN N/A
- LTRN N/A
- P/E Ratio
- MRSN N/A
- LTRN N/A
- Revenue Growth
- MRSN 16.14
- LTRN N/A
- 52 Week Low
- MRSN $5.21
- LTRN $2.55
- 52 Week High
- MRSN $70.75
- LTRN $6.12
- Technical
- Relative Strength Index (RSI)
- MRSN 47.47
- LTRN 43.80
- Support Level
- MRSN $7.04
- LTRN $3.74
- Resistance Level
- MRSN $7.49
- LTRN $4.34
- Average True Range (ATR)
- MRSN 0.44
- LTRN 0.29
- MACD
- MRSN 0.00
- LTRN -0.03
- Stochastic Oscillator
- MRSN 36.53
- LTRN 24.16
About MRSN Mersana Therapeutics Inc.
Mersana Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing antibody-drug conjugates (ADCs) that offer a clinically meaningful benefit for cancer patients with unmet needs. The Company's next-generation ADC platforms include Dolasynthen, which delivers a proprietary auristatin payload, and Immunosynthen, which delivers a proprietary stimulator of interferon genes (STING) agonist payload. Its pipeline includes Emi-Le (XMT-1660), XMT-2056, XMT-2068, and XMT-2175.
About LTRN Lantern Pharma Inc.
Lantern Pharma Inc is an AI company transforming the cost, pace, and timeline of oncology drug discovery and development. Its proprietary AI and machine learning (ML) platform, RADR, uses oncology-focused data points and advanced ML algorithms to solve billion-dollar, real-world problems in cancer drug development. The group's growing pipeline of precision therapies has been accelerated using AI and input from world-class scientific advisors and collaborators.